✨ Your Portfolio is fetched and updated from zerodha.
Small Diagnostic Chains
Market Cap
₹9,756 Cr.
P/E
61.19

Key Ratios

Market cap
Market cap
9,756 Cr
PE
PE
61.19
Prom Holding
Prom Holding
52.60 %
ROE (%)
ROE (%)
17.98
ROCE (%)
ROCE (%)
19.89
Div Yield (%)
Div Yield (%)
0.21
Sales
Sales
768 Cr
OPM (%)
OPM (%)
40.40 %
Debt to Equity
Debt to Equity
-

About

Vijaya Diagnostic Centre Limited is a rapidly expanding diagnostic chain in Southern India, of… Read more
Low
813
52W Range
High
1180
  • Vijaya Diagnostic
  • Metropolis Health.
  • Thyrocare Tech.
  • TJI Diagnostic Chains

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statement

New
Edit rows

Forensics

11 Yes

Positive for this company

2 Neutral

Neutral for this company

4 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Distribution Channel

Operational Metrics

    Select a Metric
    • Number of Diagnostic Centres (.)
    • Realization/Test - Diagnostic Centres (Rs/Test)
    • Operating Margin/Test - Diagnostic Centres (Rs/Test)
    • No of Tests - Quarterly (Mn)
    • Revenue per Footfall (Rs)
    • Quarterly Footfalls (Lakh)

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    FAQs on Vijaya Diagnostic Centre Ltd. Business

    Vijaya Diagnostic Centre Limited is a leading diagnostic chain in Southern India offering a comprehensive range of pathology and radiology tests, specialized services, and personalized health packages.

    Vijaya Diagnostic major competitors are Metropolis Health., Thyrocare Tech., Vimta Labs, Krsnaa Diagnostics, Nidan Labs. & Health, Dr. Lal Pathlabs, Medplus Health Servi.
    Market Cap of Vijaya Diagnostic is ₹9,761 Crs.
    While the median market cap of its peers are ₹6,439 Crs.

    Vijaya Diagnostic seems to be less financially stable compared to its competitors.
    Altman Z score of Vijaya Diagnostic is 14.25 and is ranked 4 out of its 8 competitors.

    Company Filing

    2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Feb May Jul Nov Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Sep Dec
    Investor Presentation Feb May Jul Nov Mar Jun Sep Dec Mar Jun Sep Dec Feb Mar May Jun Aug Sep Dec Sep Dec
    Conference Call Feb Mar Aug Nov Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Sep Dec
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material